antares pharma inc (ATRS:NASDAQ CM)
Paul K. Wotton Ph.D.
Former Chief Executive Officer, President and Director, Antares Pharma Inc.
|Age||Total Calculated Compensation||This person is connected to 25 board members in 2 different organizations across 5 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Paul K. Wotton, Ph.D. has been Chief Executive Officer and President of Ocata Therapeutics, Inc. (alternative name Advanced Cell Technology Inc.) since July 2014. Dr. Wotton has over 20 years of experience in the pharmaceutical industry with both large and specialty pharma companies. He served as the Chief Executive Officer of Antares Pharma Inc. since October 2008 until June 2014 and served as its President since July 2008 until June 2014. Dr. Wotton served as the ...
100 Princeton SouthPhone: 609-359-3020
Ewing, New Jersey 08628
Board Members Memberships*
Former Chief Executive Officer, President and Executive Director
Former Chief Executive Officer, President and Director
Chief Executive Officer, President, Director and Member of Pricing Committee
Director and Member of Corporate Governance & Nominating Committee
University Of London
Kingston Business School
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Olav Hellebo||Chief Executive Officer and Director|
ReNeuron Group plc
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|I. Richard Garr J.D.||Co-Founder, Chief Executive Officer, President, Chief Financial Officer, General Counsel and Director|
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2014.|